Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 *6 and *26.

Gatanaga, Hiroyuki; Hayashida, Tsunefusa; Tsuchiya, Kiyoto; Yoshino, Munehiro; Kuwahara, Takeshi; Tsukada, Hiroki; Fujimoto, Katsuya; Sato, Isao; Ueda, Mikio; Horiba, Masahide; Hamaguchi, Motohiro; Yamamoto, Masahiro; Takata, Noboru; Kimura, Akiro; Koike, Takao; Gejyo, Fumitake; Matsushita, Shuzo; Shirasaka, Takuma; Kimura, Satoshi; Oka, Shinichi

Gatanaga, Hiroyuki; Hayashida, Tsunefusa; Tsuchiya, Kiyoto; Yoshino, Munehiro; Kuwahara, Takeshi; Tsukada, Hiroki; Fujimoto, Katsuya; Sato, Isao; Ueda, Mikio; Horiba, Masahide; Hamaguchi, Motohiro; Yamamoto, Masahiro; Takata, Noboru; Kimura, Akiro; Koike, Takao; Gejyo, Fumitake; Matsushita, Shuzo; Shirasaka, Takuma; Kimura, Satoshi; Oka, Shinichi.

Affiliation

Gatanaga H; AIDS Clinical Center, International Medical Center of Japan, Tokyo, Japan. higatana@imcj.acc.go.jp

Clin Infect Dis ; 45(9): 1230-7, 2007 Nov 01.

Article in En | MEDLINE | ID: mdl-17918089

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oxidoreductases, N-Demethylating / Polymorphism, Genetic / Aryl Hydrocarbon Hydroxylases / HIV Infections / HIV-1 / Anti-HIV Agents / Benzoxazines Limits: Humans Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2007 Document type: Article Affiliation country: Country of publication:

Search on Google

Add to My VHL

XML

PubMed Links